Evidence map›Paper›PMID 34031552›Full record

ArticleEuropean journal of human genetics : EJHG2022

Stakeholder engagement to ensure the sustainability of biobanks: a survey of potential users of biobank services.

Corinna Klingler, Magdaléna von Jagwitz-Biegnitz, Ronny Baber, Karl-Friedrich Becker, Edgar Dahl, Cornelius Eibner, Jörg Fuchs, Maike K Groenewold, Mara Lena Hartung, Michael Hummel and 8 more

Abstract read
In one paragraph

Article in European journal of human genetics : EJHG, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Review
  2. Article
  3. Quantifying the impact of biobanks and cohort studies.Proceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors.

Corinna KlinglerGerman Biobank Node, Charité Universitätsmedizin Berlin, Berlin, Germany. germanbiobanknode@charite.de.ORCID http://orcid.org/0000-0002-8148-5999
Magdaléna von Jagwitz-BiegnitzGerman Biobank Node, Charité Universitätsmedizin Berlin, Berlin, Germany.
Ronny BaberLeipzig Medical Biobank, University Leipzig, Leipzig, Germany.
Karl-Friedrich BeckerGewebebank des Klinikums rechts der Isar und der Technischen Universität München, Am Institut für Pathologie der TU München, Trogerstr. 18, 81675, München, Germany.ORCID http://orcid.org/0000-0002-6801-4498
Edgar DahlRWTH centralized Biomaterial Bank (RWTH cBMB), Institute of Pathology, RWTH Aachen University, Aachen, Germany.
Cornelius EibnerIntegrated Biobank Jena (IBBJ), Institute for Clinical Chemistry and Laboratory Diagnostics, University Hospital Jena, Am Klinikum 1, D-07747, Jena, Germany.ORCID http://orcid.org/0000-0002-8823-8878
Jörg FuchsInterdisciplinary Bank of Biomaterials and Data Würzburg (ibdw), University Hospital of Würzburg, Straubmühlweg 2a, building A8/A9, 97078, Würzburg, Germany.
Maike K GroenewoldResearch Unit of Molecular Epidemiology/Core Facility Biobank, Institute of Epidemiology, Helmholtz Zentrum München, German Research Center for Environmental Health, Neuherberg, Germany.ORCID http://orcid.org/0000-0001-6777-0948
Mara Lena HartungGerman Biobank Node, Charité Universitätsmedizin Berlin, Berlin, Germany.
Michael HummelGerman Biobank Node, Charité Universitätsmedizin Berlin, Berlin, Germany.
Roland JahnsInterdisciplinary Bank of Biomaterials and Data Würzburg (ibdw), University Hospital of Würzburg, Straubmühlweg 2a, building A8/A9, 97078, Würzburg, Germany.
Romy KirstenNCT Liquid Biobank, National Center for Tumor Diseases and BioMaterialBank Heidelberg (BMBH), University Hospital Heidelberg, Heidelberg, Germany.
Verena KopfnagelHannover Unified Biobank, Hannover Medical School, Hannover, Germany.
Regina MaushagenInterdisciplinary Center for Biobanking-Lübeck (ICB-L), University of Lübeck, Lübeck, Germany.
Sara Yasemin NussbeckCentral Biobank UMG, University Medical Center Göttingen, Göttingen, Germany.
Anne SchonebergCentral Biobank UMG, University Medical Center Göttingen, Göttingen, Germany.
Theresa WinterIntegrated Research Biobank Greifswald, University Medicine Greifswald, Greifswald, Germany.
Cornelia SpechtGerman Biobank Node, Charité Universitätsmedizin Berlin, Berlin, Germany.

Funding

RETINAL MECHANISMS IN VISIONR01EY001711 · NEI · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI MACLEOD, DONALD I · 1985 to 2011
$3.2M
NEI NIH HHS R01 EY001711
6 · The paper itself

Abstract

Biobanks are important infrastructures facilitating biomedical research. After a decade of rolling out such infrastructures, a shift in attention to the sustainability of biobanks could be observed in recent years. In this regard, an increase in the as yet relatively low utilisation rates of biobanks has been formulated as a goal. Higher utilisation rates can only be achieved if the perspectives of potential users of biobanks-particularly researchers not yet collaborating with biobanks-are adequately considered. To better understand their perspectives, a survey was conducted at ten different research institutions in Germany hosting a centralised biobank. The survey targeted potential users of biobank services, i.e. researchers working with biosamples. It addressed the general demand for biosamples, strategies for biosample acquisition/storage and reasons for/against collaborating with biobanks. In total, 354 researchers filled out the survey. Most interestingly, only a minority of researchers (12%) acquired their biosamples via biobanks. Of the respondents not collaborating with biobanks on sample acquisition, around half were not aware of the (services of the) respective local biobank. Those who actively decided against acquiring biosamples via a biobank provided different reasons. Most commonly, respondents stated that the biosamples required were not available, the costs were too high and information about the available biosamples was not readily accessible. Biobanks can draw many lessons from the results of the survey. Particularly, external communication and outreach should be improved. Additionally, biobanks might have to reassess whether their particular collection strategies are adequately aligned with local researchers' needs.

Indexed as

Biological Specimen BanksBiomedical ResearchGermanyHumansStakeholder ParticipationSurveys and Questionnaires

Identifiers

PMID34031552
PMCPMC9712417

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.